Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ETF Opportunities Trust REX-Osprey SOL + Staking ETF (NY:SSK)

28.90 -1.02 (-3.41%)
Streaming Delayed Price Updated: 12:14 PM EDT, Oct 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about ETF Opportunities Trust REX-Osprey SOL + Staking ETF

RexShares' REX-Osprey ETFs Help Bridge The Opportunity Gap For Prospective Crypto Investors
Without hesitation, one of the strongest performances in the global capital markets stems from the broader cryptocurrency space. At its recent peak, the sector saw its total market capitalization rise... 
Via Benzinga
Topics ETFs
Rising Interest In Blockchain Applications Bolsters REX Shares' Solana Staking ETF
 
Via Benzinga
XRP ETF Sets Record For 2025 Launch Volumes, DOGE ETF Ranks In Top Five: Is This A 'Digital Asset Revolution'?
Dogecoin (CRYPTO: DOGE) and XRP (CRYPTO: XRP) saw record-breaking flows on their first ETF trading day on Thursday, igniting calls that a new digital 
Via Benzinga
Topics ETFs
Solana's Underperformance This Year Vs. Ethereum Offers A Buying Opportunity
Long term holders of the Solana (CRYPTO: SOL) cryptocurrency have had a great five years, up over 5,000% to Ethereum's (CRYPTO: ETH) 1,000% gain. This year has been more lackluster for SOL. 
Via Benzinga
Is Solana a Millionaire-Maker?
Let's review this cryptocurrency's challenges and catalysts. 
Via The Motley Fool
This Solana-Focused ETF By REX-Osprey Offers A New Way To Earn from Crypto
SSK avoids futures-based exposure and instead directly stakes Solana, aiming to generate yield from the protocol itself. 
Via Benzinga
Topics ETFs
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.